Nature's Sunshine Products (NATR) vs ProQR Therapeutics N.V. (PRQR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nature's Sunshine Products (NATR) has outperformed ProQR Therapeutics N.V. (PRQR) over the past year, losing 16.2% versus a loss of 33.5%. Over five years, NATR leads with a -18.2% price change compared with -80.1% for PRQR. ProQR Therapeutics N.V. is the larger company by market cap ($223.7 million vs $220.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NATR | PRQR |
|---|---|---|
| Share price | $12.55 | $1.59 |
| Market cap | $220.82M | $223.67M |
| 1-day change | -0.16% | +0.96% |
| YTD return | -41.75% | -22.28% |
| 1-year return | -16.20% | -33.47% |
| 5-year return | -18.22% | -80.08% |
| P/E ratio (TTM) | 12.43 | — |
| Forward P/E | 10.20 | — |
| EPS (TTM) | $1.01 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.14 | $3.10 |
| 52-week low | $12.31 | $1.33 |
| Distance from 52-week high | -55.40% | -48.87% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +143.03% | +390.85% |
| Average volume | 160.23K | 796.41K |
| Shares outstanding | 17.60M | 141.12M |
| Employees | 806 | 186 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NATR has outperformed PRQR by 17.3 percentage points over the past year.
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
About ProQR Therapeutics N.V.
PRQR stock →ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs.
Health Care · Biotechnology: Pharmaceutical Preparations · 186 employees
NATR vs PRQR FAQ
Which is bigger, Nature's Sunshine Products or ProQR Therapeutics N.V.?
ProQR Therapeutics N.V. (PRQR) is larger, with a market capitalization of $223.67M compared with $220.82M for Nature's Sunshine Products (NATR).
Which stock has performed better over the past year, NATR or PRQR?
NATR returned -16.20% over the past 12 months, compared with -33.47% for PRQR (price return, excluding dividends). Past performance does not predict future results.
Are Nature's Sunshine Products and ProQR Therapeutics N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.